Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 25, 2023

SELL
$183.71 - $210.25 $31,230 - $35,742
-170 Reduced 9.04%
1,710 $359,000
Q1 2023

Apr 28, 2023

SELL
$191.89 - $259.92 $402,969 - $545,832
-2,100 Reduced 52.76%
1,880 $379,000
Q4 2022

Jan 26, 2023

SELL
$197.11 - $250.07 $115,506 - $146,541
-586 Reduced 12.83%
3,980 $0
Q3 2022

Oct 31, 2022

SELL
$182.44 - $250.54 $134,093 - $184,146
-735 Reduced 13.87%
4,566 $899,000
Q2 2022

Jul 26, 2022

BUY
$204.13 - $302.4 $218,827 - $324,172
1,072 Added 25.35%
5,301 $1.13 Million
Q1 2022

Apr 27, 2022

SELL
$255.51 - $362.11 $96,327 - $136,515
-377 Reduced 8.18%
4,229 $1.2 Million
Q4 2021

Jan 31, 2022

SELL
$351.38 - $448.68 $541,476 - $691,415
-1,541 Reduced 25.07%
4,606 $1.74 Million
Q3 2021

Nov 03, 2021

SELL
$372.64 - $458.3 $1.2 Million - $1.48 Million
-3,219 Reduced 34.37%
6,147 $2.54 Million
Q2 2021

Jul 30, 2021

BUY
$294.17 - $371.65 $548,038 - $692,383
1,863 Added 24.83%
9,366 $3.47 Million
Q1 2021

Apr 29, 2021

SELL
$249.67 - $299.48 $1.84 Million - $2.21 Million
-7,371 Reduced 49.56%
7,503 $2.18 Million
Q4 2020

Jan 28, 2021

SELL
$222.0 - $252.62 $330,780 - $376,403
-1,490 Reduced 9.11%
14,874 $3.72 Million
Q3 2020

Oct 29, 2020

BUY
$175.56 - $226.45 $2.24 Million - $2.89 Million
12,764 Added 354.56%
16,364 $3.71 Million
Q2 2020

Jul 24, 2020

SELL
$118.84 - $189.72 $118,364 - $188,961
-996 Reduced 21.67%
3,600 $628,000
Q1 2020

Apr 29, 2020

SELL
$98.9 - $178.34 $287,502 - $518,434
-2,907 Reduced 38.74%
4,596 $580,000
Q4 2019

Jan 27, 2020

BUY
$126.05 - $152.76 $71,722 - $86,920
569 Added 8.21%
7,503 $1.15 Million
Q3 2019

Oct 28, 2019

BUY
$125.07 - $143.67 $248,639 - $285,615
1,988 Added 40.19%
6,934 $918,000
Q1 2019

Apr 30, 2019

BUY
$104.82 - $146.73 $55,764 - $78,060
532 Added 12.05%
4,946 $718,000
Q4 2018

Feb 01, 2019

SELL
$105.09 - $137.23 $421,305 - $550,155
-4,009 Reduced 47.6%
4,414 $500,000
Q2 2018

Jul 30, 2018

BUY
$102.37 - $117.25 $503,762 - $576,987
4,921 Added 140.52%
8,423 $946,000
Q1 2018

May 02, 2018

SELL
$98.19 - $115.2 $785,323 - $921,369
-7,998 Reduced 69.55%
3,502 $374,000
Q4 2017

Jan 31, 2018

BUY
$100.43 - $118.09 $258,808 - $304,317
2,577 Added 28.88%
11,500 $1.26 Million
Q3 2017

Oct 31, 2017

BUY
$96.72 - $109.26 $863,032 - $974,926
8,923
8,923 $964,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $7.66B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Dupont Capital Management Corp Portfolio

Follow Dupont Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.